Discover trends, market shifts, and competitive outlooks for the genotyping assay industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#How Has The Genotyping Assay Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_
The market size of the genotyping assay has significantly expanded in recent years. It is projected to increase from $33.98 billion in 2024 to $41.6 billion in 2025, posting a compound annual growth rate (CAGR) of 22.4%. Factors such as the use of traditional glassware, cultural and lifestyle influences, economic conditions, the expansion of the hospitality and foodservice industry, and trends in gifts and decor have all contributed to the growth in the past years._x000D_
_x000D_
In the coming years, the genotyping assay market is predicted to witness a significant surge, reaching a value of $95.5 billion in 2029, accompanied by a compound annual growth rate (CAGR) of 23.1%. This rapid expansion during the forecast period could be credited to factors such as customization and personalization trends, focus on health and wellness, the rise of e-commerce, the introduction of smart and multifunctional glassware, along with culinary and mixology trends. Other notable trends during the projected period include the innovation of materials, the introduction of original shapes and designs, intelligent glassware, specialised beverage glassware, along with features ensuring health and safety._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp_x000D_
_x000D_
#What Are the Core Growth Drivers Propelling the Genotyping Assay Market Forward?#_x000D_
The escalating incidence of genetic disorders is projected to drive the genotyping assay market’s expansion in the future. Genetic disorders refer to medical conditions arising from abnormalities or mutations in a person’s DNA. Genotyping assays perform a comparative study of the DNA of affected and healthy individuals to identify changes and potentially highlight specific genetic mutations connected to a certain genetic disorder. For instance, in June 2023, Gene People, a UK-registered charity supporting people with genetic disorders, stated that one in every 25 children in the UK was diagnosed with a genetic disorder, impacting around 30,000 newborns and young children and more than 2.4 million children and adults each year. As such, the escalating incidence of genetic disorders fuels the genotyping assay market’s growth. The genotyping assay market stands to benefit from the growing appetite for personalized medicine. Personalized medicine employs medical treatment specifically tuned to a person’s unique genetic composition, resulting in more precise and effective healthcare interventions. Genotype assays play a pivotal role in personalized medicine by analyzing an individual’s genetic makeup to adjust medical treatments, select drugs, and determine dosages based on their unique genetic profile. For instance, in January 2023, the Food and Drug Administration, a US federal agency reported that the Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, roughly 34% or 12 of them were categorized as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the burgeoning demand for personalized medicine is catalyzing the expansion of the genotyping assay market._x000D_
_x000D_
#What Segment Types Define the Genotyping Assay Market Structure?#_x000D_
The genotyping assay market covered in this report is segmented –_x000D_
_x000D_
1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics_x000D_
2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies_x000D_
3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes_x000D_
_x000D_
Subsegments:_x000D_
1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Genotyping Services, Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services_x000D_
2) By Instruments: PCR Machines, Sequencing Instruments, Microarrays_x000D_
3) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp_x000D_
_x000D_
#Which Geographic Areas Hold the Strongest Growth Potential in the Genotyping Assay Market?#_x000D_
North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Which Emerging Trends that Are Influencing theGenotyping Assay Industry Evolution?#_x000D_
Leading corporations in the genotyping assay market are innovating advancements in genomic studies, which includes the creation of CE-IVD marked assays for the detection of HIV-1 strains resistant to treatment. Specifically, the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay, is used to analyze positive HIV samples in order to identify genetic variants that could potentially resist conventional antiretroviral drugs. For instance, Thermo Fisher Scientific, an American company, unveiled the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit in January 2023. This system is tailored for clinical use and it not only identifies HIV-1 strains resistant to treatment but also exhibits distinctive features such as evaluating genomic mutations via HIV RNA and identifying drug resistance mutations utilizing gold-standard Sanger sequencing technology. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has significantly enhanced the detection of treatment-resistant HIV-1 strains, in addition to providing ready-to-use reagents and controls, meeting regulatory standards, exhibiting high-performance traits, and maintaining compatibility with existing sequencing platforms and workflows._x000D_
_x000D_
#View the full report here:#_x000D_
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report_x000D_
_x000D_
#What Is the Definition of the Genotyping Assay Market?#_x000D_
A genotyping assay is a laboratory technique or method used to determine an individual’s genetic makeup at specific genetic loci or positions within their DNA. It identifies and analyzes genetic variations, such as single nucleotide polymorphisms (SNPs) or insertions or deletions, that exist in an individual’s genome._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13444_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
